| Literature DB >> 30392952 |
Gang Xing1, Li Pan1, Ce Yi1, Xiaoran Li2, Xinyue Ge1, Ying Zhao1, Yichuang Liu1, Jinyan Li1, Anthony Woo2, Bin Lin1, Yuyang Zhang3, Maosheng Cheng4.
Abstract
A series of novel β2-adrenoceptor agonists with a 5-(2-amino-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one moiety was designed, synthesized and evaluated for biological activity in human embryonic kidney 293 cells and isolated guinea pig trachea. Compounds 9g and (R)-18c exhibited the most excellent β2-adrenoceptor agonistic effects and high β2/β1-selectivity with EC50 values of 36 pM for 9g and 21 pM for (R)-18c. They produced potent airway smooth muscle relaxant effects with fast onset of action and long duration of action in an in vitro guinea pig trachea model of bronchodilation. These results support further development of the two compounds into drug candidates.Entities:
Keywords: Asthma; COPD; Indacaterol; Salmeterol; Trantinterol; β(2)-Adrenoceptor agonist
Year: 2018 PMID: 30392952 DOI: 10.1016/j.bmc.2018.10.043
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641